At a glance
ClinicalIndex Comparison RecordN/ACompleted· 28 enrolled
Drug / intervention
EV1000™/volumeView™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a New Calibrated Pulse Wave Analysis Method(EV1000™/volumeView™) for Cardiac Output Monitoring in Adult Liver Transplantation
In Brief
An observational study evaluating EV1000™/volumeView™ for Liver Disease. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The investigators are trying to evaluate the agreement of cardiac output measurements taken using the specific thermistor-tipped arterial catheter ( the VolumeView ™ catheter) and the EV1000 ™ monitoring platform ( Edward lifesciences, Irvine, CA, USA) with measurements taken using continuous pulmonary artery thermodilution cardiac output monitoring during orthotopic liver transplantation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Disease
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartOct 2014
First PostedDec 2014
Primary CompletionSep 2015
TodayJul 2026
First PostedDec 3, 2014
Enrollment StartOct 1, 2014
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.6 years ago
Interventions
EV1000™/volumeView™device